Keyphrases
Israel
100%
Chronic Lymphocytic Leukemia
100%
Survival Trends
100%
Old Age
66%
Binet Stage
50%
Survival Rate
33%
Israeli
16%
Clinical Characteristics
16%
Leukemia Patients
16%
Clinical Data
16%
Demographic Data
16%
Working Diagnosis
16%
Life Expectancy
16%
Survival Benefit
16%
Median Survival
16%
Young Patients
16%
General Practice
16%
Clinical Survival
16%
Apparent Change
16%
β2-microglobulin (β2-MG)
16%
Incurable Disease
16%
ZAP70
16%
Chemoimmunotherapy
16%
High beta
16%
Survival Improvement
16%
Biochemistry, Genetics and Molecular Biology
Survival Rate
100%
Population
50%
Life Expectancy
50%
ZAP70
50%
Beta-2 Microglobulin
50%
Neuroscience
ZAP70
100%
Beta 2 Microglobulin
100%
Chemoimmunotherapy
100%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Survival Rate
33%
Disease
16%
Life Expectancy
16%
Population
16%
Clinical Stage
16%
Chemoimmunotherapy
16%
General Medicine
16%
Beta 2 Microglobulin
16%
Protein Kinase ZAP 70
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Survival Rate
33%
Disease
16%
Life Expectancy
16%
Beta 2 Microglobulin
16%
Protein Kinase ZAP 70
16%